How did Eli Lilly's revenue streams perform in Q1 2024?

Eli Lilly's revenue streams in Q1 2024 were primarily driven by its business segment, which includes key products such as Zyprexa and Zepbound. The segment reported a revenue of $217.5 million for the quarter.